No House member has disclosed a HR trade since 2025.
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 7, 2026 | Hull Robert EChief Operating Officer | Sale at price 19.11 per share. | 21K | $401.31K |
| Jun 22, 2026 | Callaway Amanda LOfficer | Sale at price 20.37 per share. | 25.8K | $524.87K |
| May 18, 2026 | Moore Constance B.Director | Stock Award(Grant) at price 20.20 per share. | 6.7K | $135.00K |
| May 18, 2026 | Henry David BDirector | Stock Award(Grant) at price 20.20 per share. | 6.7K | $135.00K |
| May 18, 2026 | Bohjalian Thomas NDirector | Stock Award(Grant) at price 20.20 per share. | 6.7K | $135.00K |
| May 18, 2026 | Rufrano Glenn JDirector | Stock Award(Grant) at price 20.20 per share. | 6.7K | $135.00K |
| May 18, 2026 | Wood Donald C.Director | Stock Award(Grant) at price 20.20 per share. | 6.7K | $135.00K |
| Mar 5, 2026 | Bohjalian Thomas NDirector | Purchase at price 18.09 per share. | 10K | $180.90K |
| Mar 3, 2026 | Gabbay DanielChief Financial Officer | Purchase at price 18.74 per share. | 10 | $187 |
| Feb 8, 2026 | Callaway Amanda LOfficer | Stock Award(Grant) at price 17.13 per share. | 34.7K | $594.22K |
| Feb 8, 2026 | Hull Robert EChief Operating Officer | Stock Award(Grant) at price 17.13 per share. | 33.9K | $580.00K |
| Feb 8, 2026 | Scott Peter AChief Executive Officer | Stock Award(Grant) at price 17.13 per share. | 155.9K | $2.67M |
| Feb 8, 2026 | Crowley Ryan E.Chief Investment Officer | Stock Award(Grant) at price 17.13 per share. | 32.8K | $561.66K |
| Feb 8, 2026 | Loope Andrew E.General Counsel | Stock Award(Grant) at price 17.13 per share. | 32.6K | $558.23K |
| Feb 8, 2026 | Gabbay DanielChief Financial Officer | Stock Award(Grant) at price 17.13 - 17.29 per share. | 191.2K | $3.30M |
| Dec 30, 2025 | Scott Peter AChief Executive Officer | Stock Award(Grant) at price 16.94 per share. | 6.6K | $112.48K |
| Dec 30, 2025 | Crowley Ryan E.Chief Investment Officer | Stock Award(Grant) at price 16.94 per share. | 5.8K | $99.00K |
| Sep 4, 2025 | Wilson Julie F.Officer | Sale at price 18.00 per share. | 15K | $270.00K |
| Aug 12, 2025 | Bohjalian Thomas NDirector | Purchase at price 16.46 per share. | 10K | $164.60K |
| May 19, 2025 | Moore Constance B.Chief Executive Officer | Stock Award(Grant) at price 14.97 per share. | 9K | $135.00K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.9 | 9.9 | -7.9 | 10.1 | 6.5 | 1.3 | 4.2 | -9.4 | -6.8 | -3.0 | +1.5% | ||
| 2025 | -1.2 | 2.3 | -1.3 | -8.1 | -6.6 | 9.4 | -3.2 | 13.2 | 3.7 | -1.7 | 2.9 | -7.0 | +0.0% |
| 2024 | -6.5 | -14.5 | 2.7 | 0.6 | 14.1 | 1.5 | 7.3 | 0.6 | 2.0 | -5.3 | 6.6 | -7.5 | −1.6% |
| 2023 | 11.7 | -9.4 | -0.9 | 2.3 | -5.9 | 1.3 | 3.6 | -10.3 | -12.8 | -6.0 | 6.4 | 12.8 | −10.6% |
| 2022 | -2.0 | -15.9 | 5.4 | -1.5 | 7.3 | -6.4 | -3.5 | -7.4 | -14.3 | -2.5 | 1.0 | -6.1 | −39.1% |
| 2021 | 1.4 | -3.8 | 5.1 | 6.1 | -5.7 | -0.5 | 5.6 | -5.8 | -0.8 | 11.0 | -5.3 | 1.0 | +6.9% |
| 2020 | 8.1 | -4.9 | -18.6 | 5.2 | 4.5 | -4.6 | 0.0 | -1.5 | 4.4 | -7.7 | 6.1 | 0.3 | −11.3% |
| 2019 | 13.5 | -2.0 | 1.5 | -3.8 | 4.4 | -2.9 | 2.1 | 3.9 | 0.8 | 3.8 | -4.5 | 0.5 | +17.3% |
| 2018 | -7.0 | -11.1 | 4.4 | 0.4 | -2.1 | 6.8 | 2.2 | 4.2 | -5.5 | -4.8 | 11.3 | -8.3 | −11.5% |
| 2017 | -0.4 | 5.8 | 1.7 | 0.9 | 1.4 | 2.7 | -2.5 | -0.1 | -2.8 | -0.3 | 1.6 | -2.0 | +5.9% |
| 2016 | 2.5 | -0.1 | 6.5 | -2.0 | 5.0 | 10.1 | 3.3 | -3.0 | -2.9 | -6.4 | -7.9 | 3.2 | +7.1% |
| 2015 | 10.1 | -5.2 | -2.7 | -7.8 | -7.0 | -2.4 | 3.4 | -4.7 | 8.5 | 6.1 | 3.1 | 4.2 | +3.7% |
| 2014 | 7.6 | 4.6 | 0.8 | 4.1 | -0.9 | 2.0 | -2.8 | 1.1 | -5.1 | 11.8 | -0.2 | 3.4 | +28.2% |
| 2013 | 6.1 | 4.4 | 6.7 | 5.7 | -11.4 | -4.2 | 0.8 | -12.5 | 2.8 | 3.9 | -7.8 | -3.7 | −11.2% |
| 2012 | 13.3 | -1.9 | 6.4 | -2.4 | 1.9 | 9.0 | 3.0 | -1.2 | -5.0 | 1.9 | 1.5 | 0.7 | +29.2% |
| 2011 | -0.8 | 11.0 | -2.6 | 0.6 | -3.6 | -6.3 | -5.0 | -10.8 | -3.7 | 12.1 | -6.7 | 5.5 | −12.2% |
| 2010 | -2.3 | -0.4 | 11.5 | 3.6 | -5.0 | -4.2 | 6.8 | -0.3 | -0.1 | 3.2 | -14.5 | 2.6 | −1.4% |
| 2009 | -29.7 | -12.2 | 3.5 | 12.0 | -1.9 | 2.2 | 15.3 | 11.5 | -2.4 | -1.4 | 6.0 | -2.9 | −8.6% |
| 2008 | 1.7 | -7.9 | 9.9 | 8.3 | -6.3 | -10.5 | 22.0 | -1.2 | 1.7 | -12.3 | -24.9 | 22.4 | −7.5% |
| 2007 | 7.2 | -8.6 | -3.7 | -8.7 | -3.8 | -15.2 | -16.4 | 7.5 | 6.8 | -0.8 | -3.8 | -0.2 | −35.8% |
Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt less cash. Healthcare Realty Trust Incorporated was incorporated in 1992 and is based in Nashville, United States.
Buy / hold / sell counts